<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>EFRA Inquiry on Food Security</title></head><body><div><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="font-size:14pt; line-height:115%; margin:5pt 0pt; text-align:center"><span style="font-family:Calibri; font-size:14pt; font-weight:bold">Submission by the National Office of Animal Health</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt; font-style:italic">The N</span><span style="font-family:Calibri; font-size:11pt; font-style:italic">ational Offi</span><span style="font-family:Calibri; font-size:11pt; font-style:italic">ce of Animal Health (NOAH) rep</span><span style="font-family:Calibri; font-size:11pt; font-style:italic">resents </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">around 90% of </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">the UK animal medicines industry.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt; font-style:italic">Its </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">aim is to promote the benefits of safe, effective, quality </span><span style="font-family:Calibri; font-size:11pt; font-style:italic">medicines for the health and welfare of all animals.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">NOAH</span><span style="font-family:Calibri; font-size:11pt"> welcome</span><span style="font-family:Calibri; font-size:11pt">s</span><span style="font-family:Calibri; font-size:11pt"> the chance to contribute to the EFRA Inquiry. </span><span style="font-family:Calibri; font-size:11pt">This submission is </span><span style="font-family:Calibri; font-size:11pt">primarily </span><span style="font-family:Calibri; font-size:11pt">based on work done by NOAH in preparation for a conference</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">it organised called </span><span style="font-family:Calibri; font-size:11pt">“Feeding the World” held in Februar</span><span style="font-family:Calibri; font-size:11pt">y 2011</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt">More details of presentations made at this event are available on request.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">This submission chiefly addresses </span><span style="font-family:Calibri; font-size:11pt">the area of the EFRA Inquiry</span><span style="font-family:Calibri; font-size:11pt"> where animal medicines have most relevance.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:11pt">•</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Calibri; font-size:11pt; font-style:italic; font-weight:bold">The potential value and contribution of science and GM technology to UK food security. </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">As the world population increases, demand for food from animals grows, as do concerns about the environmental impact of livestock farming, animal welfare and food safe</span><span style="font-family:Calibri; font-size:11pt">ty. </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">The world’s population is predicted to reach 9.1 billion by 2050 and the demand for food from animals is expected to increase by up to 100%. Most of the increased production needed will come from improvements and greater efficiency in production techn</span><span style="font-family:Calibri; font-size:11pt">ology. The need for technology in livestock production is not only here to stay but</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">needs</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">to grow. </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">Meat consumption will increase as the world population increases and as emerging economies become more affluent</span><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">Livestock are</span><span style="font-family:Calibri; font-size:11pt"> considered</span><span style="font-family:Calibri; font-size:11pt"> a major cause of g</span><span style="font-family:Calibri; font-size:11pt">reenhouse emissions. But livestock are essential because they utilise marginal land (hill farming in the UK for example); food from animals provide high quality protein and livestock provide a</span><span style="font-family:Calibri; font-size:11pt">n essential</span><span style="font-family:Calibri; font-size:11pt"> livelihood for world’s poorest communities</span><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">For food</span><span style="font-family:Calibri; font-size:11pt"> security i</span><span style="font-family:Calibri; font-size:11pt">ntensification and improvement of efficiency are necessary as m</span><span style="font-family:Calibri; font-size:11pt">odern farming methods can produce significantly more food than traditional systems through the use of improved genetics, improved nutrition</span><span style="font-family:Calibri; font-size:11pt">, improved health</span><span style="font-family:Calibri; font-size:11pt"> and via economies of scal</span><span style="font-family:Calibri; font-size:11pt">e.  </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">Animal welfare and productivity.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">Animal disease can cause significant losses to the agricultural sector as well as impacting negatively on animal welfare.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">In the UK during the Bovine Spongiform Encephalopathy (BSE) epidemic more than 179,000 cattle we</span><span style="font-family:Calibri; font-size:11pt">re infected and 4.4 million slaughtered during the eradication programme.</span><span style="color:#0000ff; font-family:Calibri; font-size:7.33pt; text-decoration:underline; vertical-align:super">[]</span><span style="font-family:Calibri; font-size:11pt">In recent years, outbreaks of Avian influenza resulted in the slaughter of over 100 million birds in Asia. Not only does animal disease cause suffering and death in animals, it also</span><span style="font-family:Calibri; font-size:11pt"> affects productivity. Overall, livestock efficiency is reduced by at least 20% by disease, meaning less food produced. Infectious disease in animals can also pose a threat to human health – up to 70% of human infectious diseases have their source in anima</span><span style="font-family:Calibri; font-size:11pt">ls.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">NOAH believes animal medicines have an important </span><span style="font-family:Calibri; font-size:11pt">and essential </span><span style="font-family:Calibri; font-size:11pt">role to play in addressing these issues: The development and effective use of veterinary medicines</span><span style="font-family:Calibri; font-size:11pt">, </span><span style="font-family:Calibri; font-size:11pt">particularly</span><span style="font-family:Calibri; font-size:11pt"> vaccines,</span><span style="font-family:Calibri; font-size:11pt"> to combat disease is the most direct route for the animal health i</span><span style="font-family:Calibri; font-size:11pt">ndustry to contribute to the efficient rearing of livestock without compromising animal and human health or the environment.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">There are many factors that affect the welfare of an animal but </span><span style="font-family:Calibri; font-size:11pt">the </span><span style="font-family:Calibri; font-size:11pt">essential pre-requisite for the welfar</span><span style="font-family:Calibri; font-size:11pt">e of any animal</span><span style="font-family:Calibri; font-size:11pt">, and inde</span><span style="font-family:Calibri; font-size:11pt">ed its productivity,</span><span style="font-family:Calibri; font-size:11pt"> is good health</span><span style="font-family:Calibri; font-size:11pt">.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">Overall livestock production efficiency globally is reduced at least 20% by disease </span><span style="font-family:Calibri; font-size:11pt">(</span><span style="font-family:Calibri; font-size:11pt">source: </span><span style="font-family:Calibri; font-size:11pt">FAO; OIE)</span></p><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">Vaccination has been successful in the control of diseases such as Rinderpest (not endemic in the UK), which</span><span style="font-family:Calibri; font-size:11pt"> used to kill up to 90% of cattle in affected herds in the 1980’s, but in 2010 </span><span style="font-family:Calibri; font-size:11pt">was</span><span style="font-family:Calibri; font-size:11pt"> entirely eradicated thanks to international co-operation and the use of a safe, effective vaccine. Fifteen years ago</span><span style="font-family:Calibri; font-size:11pt">,</span><span style="font-family:Calibri; font-size:11pt"> to create a new vaccine for any disease would have alwa</span><span style="font-family:Calibri; font-size:11pt">ys taken many years (the average time for livestock products is 8-12 years) but with modern technologies we have been able to bring a vaccine to the market within a year, as demonstrated by the Bluetongue Virus outbreak and its successful control in 2007/0</span><span style="font-family:Calibri; font-size:11pt">8. If Bluetongue, which had previously been exotic to Northern Europe, had taken hold in the UK up to 35 million sheep and 10 million cattle could have faced infection</span><span style="font-family:Calibri; font-size:11pt">, which would have had a devastating impact on productivity, welcome and cost to the farm</span><span style="font-family:Calibri; font-size:11pt">ing industry and indirectly the consumer</span><span style="font-family:Calibri; font-size:11pt">. The </span><span style="font-family:Calibri; font-size:11pt">prompt </span><span style="font-family:Calibri; font-size:11pt">availability of an effective vaccine allowed farmers to take steps to protect their livestock by vaccinating.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">There are a number of endemic diseases in the UK that we have still not controlled, for examp</span><span style="font-family:Calibri; font-size:11pt">le BVD </span><span style="font-family:Calibri; font-size:11pt">(Bovine Viral Diarrhoea) </span><span style="font-family:Calibri; font-size:11pt">is estimated to be present in 70% of the UK dairy herd. It is not a zoonotic</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">disease (ie one that is passed between animals and people)</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">so there are no food safety issues, but is it very damaging to fertility and productivit</span><span style="font-family:Calibri; font-size:11pt">y. We have vaccines on the market to protect cattle, and whilst we accept that vaccination alone is not the solution, as it must be tackled in conjunction with better biosecurity. But through knowledge transfer and better awareness we could eradicate this </span><span style="font-family:Calibri; font-size:11pt">disease. Many other member states have successfully achieved this goal and we can too – but we have to work together.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">We could improve food productivity tomorrow if we put to use the existing medicines and vaccines we already have to </span><span style="font-family:Calibri; font-size:11pt">their full potential a</span><span style="font-family:Calibri; font-size:11pt">nd continued </span><span style="font-family:Calibri; font-size:11pt">correct use. We must also make sure that those medicines are used responsibly and that is why NOAH is so closely engaged with, and committed to, the work of the Responsible Use of Animal Medicines Alliance (RUMA) which sets out guidelines for </span><span style="font-family:Calibri; font-size:11pt">responsible use of antibiotics and anthelmintics.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">Getting a veterinary medicine to market is a long process and quite rightly has many regulatory hurdles. Whilst safety is paramount we have to balance this with pragmatism and not overly apply the Precautio</span><span style="font-family:Calibri; font-size:11pt">nary Principle. We cannot live in a world of zero tolerance. A lot of the regulations our industry has to work under are derived from the human regulatory processes, many of which we consider are not necessary for animal medicines, therefore that is why NO</span><span style="font-family:Calibri; font-size:11pt">AH and the collective animal industry are working through the European federation for animal health IFAH-Europe to put forward proposals to the next review of the European Directives to support a single regulatory process</span><span style="font-family:Calibri; font-size:11pt"> – the so called 1-1-1 concept of o</span><span style="font-family:Calibri; font-size:11pt">ne dossier, one assessment, one decision</span><span style="font-family:Calibri; font-size:11pt">. This will provide dedicated regulatory process for the animal medicines industry, with still the same high emphasis on safety, efficacy and quality – but also a true ‘common market’ by allowing all medicines author</span><span style="font-family:Calibri; font-size:11pt">ised </span><span style="font-family:Calibri; font-size:11pt">in any member state to be available on any member state market. This </span><span style="font-family:Calibri; font-size:11pt">is needed to</span><a name="_GoBack"></a><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">increase availability of medicines and speed up time to market. The draft legislation is expected from the European Commission in February 2014.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">Research and Development</span><span style="font-family:Calibri; font-size:11pt"> for animal medicines is now truly global </span><span style="font-family:Calibri; font-size:11pt">but n</span><span style="font-family:Calibri; font-size:11pt">evertheless NOAH and the UK industry still plays its part. </span><span style="font-family:Calibri; font-size:11pt">The</span><span style="font-family:Calibri; font-size:11pt"> UK Mirror group for the European Technology Platform for Global Animal </span><span style="font-family:Calibri; font-size:11pt">Health,</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">an organisation that brings together the animal medicine industry, </span><span style="font-family:Calibri; font-size:11pt">the veterinary profession, farmers, and academic researchers to identify disease threats within Europe and gaps where treatments or vaccines are unavailable, </span><span style="font-family:Calibri; font-size:11pt">(see DisConTools </span><span style="font-family:Calibri; font-size:11pt">at </span><span style="font-family:Calibri; font-size:11pt">http://www.discontools.eu/</span><span style="font-family:Calibri; font-size:11pt">) </span><span style="font-family:Calibri; font-size:11pt">has identified the key disease threats to the UK </span><span style="font-family:Calibri; font-size:11pt">emanating from the global food chain and strives to get our centres of excellence for Research and Development in the UK working for and contributing to the needs of the market in the future as well as enhancing medicines and vaccines for existing endemic </span><span style="font-family:Calibri; font-size:11pt">diseases in the UK.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">Many vaccines still in use are derived from old technology (bacterins and whole virus preparations) despite the promise of molecular biology being so great. These have a proven track record – they are familiar</span><span style="font-family:Calibri; font-size:11pt">, effective</span><span style="font-family:Calibri; font-size:11pt"> and safe</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">And </span><span style="font-family:Calibri; font-size:11pt">although there have been some successes</span><span style="font-family:Calibri; font-size:11pt"> with new technologies bringing new vaccination solutions</span><span style="font-family:Calibri; font-size:11pt">, biotechnology still has some hurdles to overcome</span><span style="font-family:Calibri; font-size:11pt">, not least of which is perception and misconception.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">Addressing misconceptions </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">Despite the </span><span style="font-family:Calibri; font-size:11pt">benefits </span><span style="font-family:Calibri; font-size:11pt">that ani</span><span style="font-family:Calibri; font-size:11pt">mal medicines can bring</span><span style="font-family:Calibri; font-size:11pt">, with the publicity surrounding BSE, Bird Flu, Foot and Mouth Disease etc, it was perceived that consumer anxiety over food safety had grown. </span><span style="font-family:Calibri; font-size:11pt">In 2010 and in preparation for the 2011 </span><span style="font-family:Calibri; font-size:11pt">NOAH ‘Feeding the World’ c</span><span style="font-family:Calibri; font-size:11pt">onference,</span><span style="font-family:Calibri; font-size:11pt"> NOAH decided </span><span style="font-family:Calibri; font-size:11pt">to find out what the consumer knew</span><span style="font-family:Calibri; font-size:11pt"> and did not know about vaccines</span><span style="font-family:Calibri; font-size:11pt"> and to </span><span style="font-family:Calibri; font-size:11pt">see what</span><span style="font-family:Calibri; font-size:11pt"> misconceptions</span><span style="font-family:Calibri; font-size:11pt"> existed</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt">These misconceptions were explored further through another survey in 2012</span><span style="font-family:Calibri; font-size:11pt"> (which was reported at a follow-up NOAH conference earlier in 2013 on ‘Addr</span><span style="font-family:Calibri; font-size:11pt">essing misconceptions about animal medicines’</span><span style="font-family:Calibri; font-size:11pt">. </span><span style="font-family:Calibri; font-size:11pt">It found although there is trust in the system regulating animal medicines, there is still misunderstanding among the public about their role in livestock production. One of the key concerns was that vaccines </span><span style="font-family:Calibri; font-size:11pt">would be transferred to food, which of course is not the case. There is extremely rigorous testing overseen by an independent body, the Veterinary Residues Committee (VRC)</span><span style="font-family:Calibri; font-size:11pt">, reporting to the Veterinary Medicines Directorate</span><span style="font-family:Calibri; font-size:11pt">, to make sure harmful animal </span><span style="font-family:Calibri; font-size:11pt">medicine residues do</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">n</span><span style="font-family:Calibri; font-size:11pt">o</span><span style="font-family:Calibri; font-size:11pt">t get into the food chain. The VRC reports no residues of concern in UK</span><span style="font-family:Calibri; font-size:11pt"> food</span><span style="font-family:Calibri; font-size:11pt">. </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">NOAH, along with others involved with medicines for livestock production, are working to see how best to provide information to help address misconception</span><span style="font-family:Calibri; font-size:11pt">s amongst consumers.</span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt; font-weight:bold">In conclusion:</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 31.35pt; padding-left:4.65pt; text-align:justify; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">Intensive livestock production will continue to be needed due to increasing product demand</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><ol start="2" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 31.35pt; padding-left:4.65pt; text-align:justify; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">Disease risks will increase, due </span><span style="font-family:Calibri; font-size:11pt">to </span><span style="font-family:Calibri; font-size:11pt">climate change</span><span style="font-family:Calibri; font-size:11pt">,</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">intensification </span><span style="font-family:Calibri; font-size:11pt">and increasing transport and travel</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><ol start="3" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 31.35pt; padding-left:4.65pt; text-align:justify; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">Overall livestock produ</span><span style="font-family:Calibri; font-size:11pt">ction efficiency is reduced at least 20% by disease</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><ol start="4" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 0pt 31.35pt; padding-left:4.65pt; text-align:justify; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">Emerging diseases pose a significant challenge to animal and human health</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 31.35pt; padding-left:4.65pt; text-align:justify; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">Therefore there is a continuing need for effective </span><span style="font-family:Calibri; font-size:11pt">animal </span><span style="font-family:Calibri; font-size:11pt">medicines and vaccines and for the continued development of new and be</span><span style="font-family:Calibri; font-size:11pt">tter products</span></li></ol><ol start="5" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 31.35pt; padding-left:4.65pt; text-align:justify; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">New developments in molecular biology and genomics will result in the rapid development of novel, more effective medicines</span></li><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 31.35pt; padding-left:4.65pt; text-align:justify; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">Immunological methods will also be increasingly applied to parasites, mastitis and reproductive control</span></li><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 31.35pt; padding-left:4.65pt; text-align:justify; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">Initiatives like the ETPGAH (European Technology Platform for Global Animal Health) and GALVmed </span><span style="font-family:Calibri; font-size:11pt">(Global Alliance for Livestock Veterinary Medicines) </span><span style="font-family:Calibri; font-size:11pt">will be increasingly necessary to coordinate and fund the development of new animal medicines</span></li><li style="font-family:Calibri; font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 31.35pt; padding-left:4.65pt; text-align:justify; text-indent:0pt"><span style="font-family:Calibri; font-size:11pt">Exploitation </span><span style="font-family:Calibri; font-size:11pt">of modern molecular and genetic technologies could be controversial and therefore clear and transparent regulation is necessary</span><span style="font-family:Calibri; font-size:11pt">, as well as clear communication to </span><span style="font-family:Calibri; font-size:11pt">consumers to</span><span style="font-family:Calibri; font-size:11pt"> </span><span style="font-family:Calibri; font-size:11pt">address misconceptions.</span></li></ol><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt 18pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">Animal science has a part to play in food security today, and the </span><span style="font-family:Calibri; font-size:11pt">potential </span><span style="font-family:Calibri; font-size:11pt">to change lives</span><span style="font-family:Calibri; font-size:11pt"> for the better</span><span style="font-family:Calibri; font-size:11pt"> in the future.</span><span style="font-family:Calibri; font-size:11pt"> The animal medicines </span><span style="font-family:Calibri; font-size:11pt">industry </span><span style="font-family:Calibri; font-size:11pt">is working to stay </span><span style="font-family:Calibri; font-size:11pt">ahead of the curve, and play </span><span style="font-family:Calibri; font-size:11pt">its</span><span style="font-family:Calibri; font-size:11pt"> part in contributing to the future security of the w</span><span style="font-family:Calibri; font-size:11pt">orld’s food supply. </span></p><p style="font-size:11pt; line-height:115%; margin:0pt 0pt 10pt; text-align:justify"><span style="font-family:Calibri; font-size:11pt">December 2013</span></p><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p></div></body></html>